Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 15, 2006

View Archived Issues

KKJA-0036: novel T-type calcium channel blocker is effective against visceral pain

Medicure looks back on fiscal 2006

CRTH2 receptor identified as a novel therapeutic target for chronic allergic skin inflammation

Spotlight on aspirin: Novel non-COX-1-mediated pathways involved in antithrombotic effects

Preliminary results from phase III study of CIP-Tramadol ER

Enrollment under way in phase IIa safety study of NTx-265 in stroke

Tripos and CeNeS extend COMT inhibitor research agreement

Plans for primate study of BrainStorm's Parkinson's disease stem cell therapy

SIGA receives grant to support Lassa fever virus antiviral program

Curis establishes Chinese presence, updates key program progress

VQD-002 studied for leukemia in new phase I/II trial

Higher doses of Viramidine to be examined following phase III findings

OrCel superior to standard of care in healing difficult to heal venous leg ulcers

BioLineRx inlicenses BL-3030 for inflammatory diseases

Sugars from avocado enhance cutaneous defense mechanisms

TB4 significantly improves cardiac function following heart attack in animal study

Discovery Partners International stockholders approve Infinity merger

Recent patents describe new agents for endocrine-related disorders

New therapeutic agents for urological disorders imparted in recent patents

Compounds with potential use in neurological disorders disclosed

Good oral bioavailability and safety profile for new oxytocin antagonist

Component of brown seaweed shows antiobesity properties

Argenta Discovery reports on novel histone deacetylase inhibitors

Potentially new antiinflammatory drugs targeting mPGES-1 presented by Merck

Romidepsin studied in combination with gemcitabine in new trial

Radius and Karo Bio announce licensing agreement for novel SARMs

Preclinical testing for Advanced Refractive Technologies' novel glaucoma treatment

ADA/EASD consensus recommends metformin at diagnosis of type 2 diabetes

Invirase 500 mg launched in Japan

Valtrex approved in Japan to prevent recurrence of genital herpes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...